Container closure system
First Claim
1. A pharmaceutical product comprisingan overpouch with an intransparent first foil and a transparent second foil, wherein the intransparent first foil comprises a colored polymeric layer, anda transparent primary container containing a pharmaceutical formulation, wherein the transparent primary container is packed within the overpouch and labeled with at least one label comprising a barcode or a data matrix and wherein the label is machine-readable through the transparent second foil of the overpouch, andwherein the at least one label has a reflection RL for light in the range of 350 nm to 800 nm and an inner surface of the intransparent first foil of the overpouch has a reflection RF for light in the direction of the primary container in the range of 350 nm to 800 nm, wherein RL≠
- RF, and wherein 0.5×
RF≥
RL and RF≥
0.5.
1 Assignment
0 Petitions
Accused Products
Abstract
The invention relates to a pharmaceutical product or container closure system containing an overpouch with an intransparent first foil and a transparent second foil, a transparent primary container for holding a transparent liquid, e.g., a pharmaceutical formulation, wherein the transparent primary container is packed within the overpouch and labeled with at least one label and wherein the at least one label acts as a light absorbing segment having a reflection RL for light in the range of about 350 nm to about 800 nm and an inner surface of the intransparent first foil of the overpouch acts as a light reflecting background having a reflection RF for light in the direction of the primary container in the range of about 350 nm to about 800 nm with RF≠RL. By the transparent second foil and the inventive reflection properties it is achieved that the at least one label on the primary container is visible and readable. Additionally, visual inspection of the content of the transparent primary container is possible. A good contrast is achieved to enhance machine and human readability.
18 Citations
25 Claims
-
1. A pharmaceutical product comprising
an overpouch with an intransparent first foil and a transparent second foil, wherein the intransparent first foil comprises a colored polymeric layer, and a transparent primary container containing a pharmaceutical formulation, wherein the transparent primary container is packed within the overpouch and labeled with at least one label comprising a barcode or a data matrix and wherein the label is machine-readable through the transparent second foil of the overpouch, and wherein the at least one label has a reflection RL for light in the range of 350 nm to 800 nm and an inner surface of the intransparent first foil of the overpouch has a reflection RF for light in the direction of the primary container in the range of 350 nm to 800 nm, wherein RL≠ - RF, and wherein 0.5×
RF≥
RL and RF≥
0.5. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22)
- RF, and wherein 0.5×
-
23. A container closure system comprising
an overpouch with an intransparent first foil and a transparent second foil, wherein the intransparent first foil comprises a colored polymeric layer, and a transparent primary container for holding a liquid, wherein the transparent primary container is packed within the overpouch and labeled with at least one label comprising a barcode or a data matrix and wherein the label is machine-readable through the transparent second foil of the overpouch and wherein the at least one label has a reflection RL for light in the range of about 350 nm to about 800 nm and an inner surface of the intransparent first foil of the overpouch has a reflection RF for light in the direction of the primary container in the range of 350 nm to 800 nm, wherein RL≠ - RF, and wherein 0.5×
RF≥
RL and RF≥
0.5. - View Dependent Claims (24)
- RF, and wherein 0.5×
-
25. A pharmaceutical product comprising
an overpouch with an intransparent first foil and a transparent second foil, wherein the intransparent first foil comprises a colored polymeric layer, a transparent primary container containing a pharmaceutical formulation, wherein the transparent primary container is packed within the overpouch and labeled with at least one label comprising a barcode or a data matrix and wherein the label is machine-readable through the transparent second foil of the overpouch and wherein the at least one label has a reflection RL for light and an inner surface of the intransparent first foil of the overpouch has a reflection RF for light in the direction of the primary container, wherein 0.5× - RF≥
RL and RF≥
0.5.
- RF≥
Specification
-
- Resources
-
Current AssigneeFresenius KABI Deutschland GmbH (Else Kröner-Fresenius-Stiftung)
-
Original AssigneeFresenius KABI Deutschland GmbH (Else Kröner-Fresenius-Stiftung)
-
InventorsJobstl, Elisabeth, Wegner, Gerald, Solberg-Eriksen, Asbjorn, Delaporte, Eric
-
Primary Examiner(s)Ackun, Jacob K
-
Assistant Examiner(s)Pagan, Jenine
-
Application NumberUS14/819,356Publication NumberTime in Patent Office1,287 DaysField of Search206438, 2065241, 2065243, 2065242, 2065246, 2065247, 206484, 2064841, 2064842, 383106, 383116, 383109, 383113, 604408, 604410, 604403, 604415US Class CurrentCPC Class CodesA61J 1/10 Bag-type containersA61J 1/1468 Containers characterised by...A61J 1/16 Holders for containersB65D 2203/02 LabelsB65D 2203/06 Arrangements on packages co...B65D 25/205 Means for the attachment of...B65D 31/02 with laminated wallsB65D 33/004 Information or decoration e...B65D 77/04 Articles or materials enclo...
